Rocket


News + Filings
Transactions





RIGGS RORY B

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
09/30/2023Intra-Cellular Therapies, Inc.ITCIGrantCommon Stock345$52.09$18k 09/30/2023
08/08/2023Royalty Pharma plcRPRXGiftLP interests in RPI US Partners 2019, LP6.5k$0.00$0 08/08/2023
06/30/2023Intra-Cellular Therapies, Inc.ITCIGrantCommon Stock279$63.32$17.7k 06/30/2023
06/01/2023Cibus, Inc.CLXTPurchaseClass A Common Stock1000$31.50$31.5k 05/31/2023
05/31/2023Cibus, Inc.CLXTGrantClass B Common Stock1.4M$0.00$0 05/31/2023
05/31/2023Cibus, Inc.CLXTGrantClass B Common Stock20.9k$0.00$0See footnote05/31/2023
05/31/2023Cibus, Inc.CLXTGrantClass B Common Stock1.5M$0.00$0See footnote05/31/2023
05/31/2023Cibus, Inc.CLXTGrantCibus Common Units1.4M$0.00$0 05/31/2023
05/31/2023Cibus, Inc.CLXTGrantCibus Common Units20.9k$0.00$0See footnote05/31/2023
05/31/2023Cibus, Inc.CLXTGrantCibus Common Units1.5M$0.00$0See footnote05/31/2023
05/31/2023Cibus, Inc.CLXTGrantClass A Common Stock848.7k$0.00$0 05/31/2023
05/31/2023Cibus, Inc.CLXTGrantClass A Common Stock2.9k$0.00$0See footnote05/31/2023
05/31/2023Cibus, Inc.CLXTGrantClass A Common Stock118.9k$0.00$0See footnote05/31/2023
05/31/2023Cibus, Inc.CLXTGrantClass A Common Stock5.4k$0.00$0 05/31/2023
05/31/2023Cibus, Inc.CLXTGrantClass A Common Stock9.6k$0.00$0By spouse05/31/2023
05/31/2023Cibus, Inc.CLXTGrantClass A Common Stock168k$0.00$0 05/31/2023
05/22/2023Royalty Pharma plcRPRXSaleClass A Ordinary Shares1.8M$32.82$57.4M 05/22/2023
05/09/2023Royalty Pharma plcRPRXConversionClass A Ordinary Shares300k$0.00$0 05/09/2023
05/09/2023Royalty Pharma plcRPRXConversionLP interests in RPI US Partners 2019, LP30k$0.00$0 05/09/2023
03/31/2023Intra-Cellular Therapies, Inc.ITCIGrantCommon Stock313$54.15$16.9k 03/31/2023
12/30/2022Intra-Cellular Therapies, Inc.ITCIGrantCommon Stock321$52.92$17k 12/30/2022
12/09/2022Royalty Pharma plcRPRXSaleClass A Ordinary Shares20k$42.07$840.9k 12/09/2022
11/17/2022Royalty Pharma plcRPRXSaleClass A Ordinary Shares120k$42.33$5.1M 11/17/2022
09/30/2022Intra-Cellular Therapies, Inc.ITCIGrantCommon Stock365$46.53$17k 09/30/2022
09/15/2022Royalty Pharma plcRPRXSaleClass A Ordinary Shares52k$42.21$2.2M 09/14/2022
09/14/2022Royalty Pharma plcRPRXSaleClass A Ordinary Shares48k$42.41$2M 09/14/2022
08/09/2022Royalty Pharma plcRPRXSaleClass A Ordinary Shares45k$43.73$2M 08/09/2022
06/30/2022Intra-Cellular Therapies, Inc.ITCIGrantCommon Stock289$57.08$16.5k 06/30/2022
06/29/2022Royalty Pharma plcRPRXSaleClass A Ordinary Shares30k$42.17$1.3M 06/29/2022
06/09/2022Intra-Cellular Therapies, Inc.ITCIGrantStock Option (right to buy)16.8k$55.48$929.7k 06/09/2022
05/20/2022Royalty Pharma plcRPRXSaleClass A Ordinary Shares123.7k$39.28$4.9M 05/19/2022
05/19/2022Royalty Pharma plcRPRXSaleClass A Ordinary Shares26.3k$40.09$1.1M 05/19/2022
03/31/2022Intra-Cellular Therapies, Inc.ITCIGrantCommon Stock257$61.19$15.7k 03/31/2022
03/29/2022Royalty Pharma plcRPRXSaleClass A Ordinary Shares60k$38.59$2.3M 03/29/2022
03/21/2022Royalty Pharma plcRPRXSaleClass A Ordinary Shares25.5k$39.05$997.6kBy New Ventures Select03/17/2022
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy